- Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy
Kerstin Zwirner et al, 2018, Radiotherapy and Oncology CrossRef - Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study
Elif Aras et al, 2020, Supportive Care in Cancer CrossRef - Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
Pere Gascon et al, 2019, BioDrugs CrossRef - Commentary - A comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars and Intended Copy Biologics in treating chemotherapy associated febrile neutropenia
P.G. Cornes et al, 2020, Toxicology and Applied Pharmacology CrossRef